(Q35183650)

7 August 2017

1 reference

title

Prostate cancer biomarkers: a current perspective (English)

1 reference

7 August 2017

0 references

1 reference

Chandan Kumar-Sinha

1

1 reference

7 August 2017

Daniel R Rhodes

series ordinal

2

1 reference

7 August 2017

Jianjun Yu

series ordinal

3

1 reference

7 August 2017

Arul M Chinnaiyan

series ordinal

4

1 reference

7 August 2017

1 July 2003

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

7 August 2017

1 reference

7 August 2017

3

1 reference

7 August 2017

459-470

1 reference

7 August 2017

4

1 reference

Bloodborne biomolecular markers in prostate cancer development and progression

7 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Prognostic markers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Current status of the molecular genetics of human prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Tumour suppressor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Prognostic factors in prostate and testis cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

DNA-based detection of prostate cancer in urine after prostatic massage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Preneoplastic prostate lesions: an opportunity for prostate cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Androgens and the control of lipid metabolism in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Endothelin B receptor gene hypermethylation in prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Dysregulation of the annexin family protein family is associated with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Gene expression analysis of prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Fingerprinting the circulating repertoire of antibodies from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

Chromosomal changes during development and progression of prostate adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

21 January 2018

The silence of the genes

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.459

21 January 2018

Identifiers

DOI

10.1586/14737159.3.4.459

1 reference

7 August 2017

1 reference